Search Results for john rogers

News roundup: Proteus may be no-teous, DOJ leads on Google-Fitbit, HHS’ mud fight, Leeds leading in health tech, malware miseries, comings and goings

...home to over 250 health tech companies and holds an annual Leeds Digital Festival in the spring [TTA 11 April]. Ransomware attack hits Hackensack Meridian. Systems were down for about a week. While this large New Jersey health system hasn’t admitted it, sources told the Asbury Park Press that it was ransomware. And if it’s not ransomware, its Emotet and Trickbot. Read ZDNet and be very apprehensive for 2020, indeed, as apparently healthcare is just one big target. Comings and Goings: There may be some end of year bombshells, but after last week’s big news about John Halamka, it’s been... Continue Reading

News roundup: Philips allies with Humana for pop health, Dexcom’s outage outrage, Halamka ankles Lahey for Mayo, Google and NHS Wales changes, Agfa’s health sale, Victrix/WhatsApp, more

...Dexcom was not only blasted by users on the server outage, which they attributed to ‘overload’, but also on its communications of the problem to users which depended on Facebook postings and not on real-time direct contacts or messaging. It was a ‘big surprise’ to their CEO, who also dismissed the possibility of a data breach, which seems a bit premature. Both Google and Microsoft provide cloud and tech services to Dexcom. CNBC 12/2, 12/3 Comings and goings: HIT pioneer, strategist, and general guru John Halamka is following the AI Star, leaving Boston’s Beth Israel Lahey Health to head up... Continue Reading

Comings and goings, short takes, and in other news…: Vivify’s new SVP Sales, Parks’ Connected Health Summit, $35M for 3D portable ultrasound, Oxford Medical Sim new pilot

...hit the market at about half the price and raised $250 million. Now Redwood City, California startup Exo Imaging has gained a $35 million Series B round to develop its portable ultrasound that through AI assistance generates a 3D image. Release. Mobihealthnews The UK’s Oxford Medical Simulation has picked up another pilot of their Oculus Rift VR headsets to simulate in-practice interactive patient treatment at the OxSTaR (Oxford Simulation, Teaching and Research) center, part of John Radcliffe Hospital, Oxfordshire. We covered OMS in April with their pilot with Health Education England Wessex at the Portsmouth and Southampton Hospitals. Mobihealthnews  ... Continue Reading

News roundup: docs dim on AI without purpose, ‘medtail’ a mall trend, CVS goes SDH, Kvedar to ATA, Biden ‘moonshot’ shorts out, and Short Takes

...housing investments and a five-year community health initiative. Forbes, Mobihealthnews ATA announces Joseph Kvedar, MD, as President-Elect. Dr. Kvedar was previously president in 2004-5 and replaces John Glaser, PhD, Executive Senior Advisor, Cerner. He will remain as Vice President of Connected Health at Partners HealthCare and Professor of Dermatology at Harvard Medical School. A question mark for those of us in the industry is his extensive engagement with October’s Connected Health Conference in Boston, one of the earliest and now a HIMSS event. ATA’s next event is ATA2020 3-5 May 2020 in Phoenix–apparently no Fall Forum this year. The Biden... Continue Reading

The Theranos Story, ch. 60: becoming a Cautionary Tale of Silicon Valley Ethics

It’s just weird. It’s just a bit surreal. When you see someone have this situation and pretend that everything is normal. It’s so bizarre.–Erika Cheung, former Theranos lab associate, whistleblower Will health tech learn its lesson? As in Chapter 58, we are now in Full Retrospective on Theranos, with Cautionary Tales abounding. One of the better ones is from one of the two young whistleblowers profiled in John Carreyrou’s ‘Bad Blood’, Erika Cheung. She was the young (23) lab associate who saw patient samples from Walgreens and other patients constantly fail quality controls, finally reported it to regulators when nobody... Continue Reading

The Theranos Story, ch. 59: there’s life left in the corporate corpse–patents! And no trial date in sight.

...Theranos president Ramesh ‘Sunny’ Balwani has been delayed indefinitely. Originally reported to be summer entertainment with a start date of 8 July, the judge set the next status conference for the case for 1 July, but refused to set a trial date, which means that the trial may not begin till next year. According to the San Jose Mercury News, the defense is seeking materials from the FDA and CMS, which are, according to defense lawyer, lawyer Kevin Downey, are “in many instances exculpatory.” Ms. Holmes’ lawyers are also seeking information on the communications between John Carreyrou of the Wall... Continue Reading

News roundup: of logos and HIMSS roundups, Rock Health’s Digital Health Consumer Adoption survey, and the millennial/Gen Z walkaway from primary care

...roundup, and Dr Jayne’s Curbside Consult on John Halamka’s world travels, including nascent care coordination in China and interoperability in Australia. Rock Health’s survey of consumer attitudes towards digital health adoption leads with these insights: Wearable use is shifting away from fitness toward managing health conditions There was a 10% increase in use of wearables to manage health, corresponding to a 10% decline in physical activity tracking Telemedicine adoption is climbing, with urban consumers more than twice as likely to use live video telemedicine than rural consumers Paradoxical but true, in terms of adoption of at least one form, it... Continue Reading

The Theranos Story, ch. 58: with HBO and ABC, let the mythmaking and psychiatric profiling begin! (updated)

...the gap in Elizabeth Holmes’ ethical makeup, including the Big Steal of Ian Gibbons’ IP. His position is somewhat complicated by a patent dispute (settled) between Dr. Fuisz & Son and Theranos. He’s still hammering on at it on Twitter (@rfuisz). What’s missing? Much credit to the estimable John Carreyrou, who broke the story in the Wall Street Journal and got his livelihood (and perhaps a few other things) threatened a few times by Tough Guy Lawyer David Boies. (Updated) At least it is here in a Vanity Fair article on the Last Days of Theranos, where they had to... Continue Reading

Where’s the evidence? Healthcare unicorns lack the proof and credibility of peer-reviewed studies.

...transparency at an early stage. Instead, these unicorns largely rely on ‘stealth research’–a term coined by Dr. John P.A. Ioannidis, the co-director of the Meta-Research Innovation Center at Stanford University (METRICS). He summed it up in his latest peer-reviewed paper, “Stealth research: lack of peer-reviewed evidence from healthcare unicorns” (co-authored with Ioana A. Cristea and Eli M. Cahan), published in the European Journal of Clinical Investigation 28 Jan: In 2014, one of us (JPAI) wrote a viewpoint article coining the term “stealth research” for touted biomedical innovation happening outside the peer-reviewed literature in a confusing mix of “possibly brilliant ideas,... Continue Reading

Is Babylon Health the next Theranos? Or just being made out to be by the press? (Soapbox)

...with distressed users create a sensational cast and skew the finished result. We hope Ms. Olson continues to investigate and publish like the estimable John Carreyrou with Theranos–unlike The Fraud That Was Theranos, she has an opportunity to be part of making Babylon a better company. Babylon also owes her some answers and transparency. we hope she continues to pursue the story. At this point, there’s no evidence that Babylon is vaporware. There are no non-working Edison machines and miniLabs which Theranos hid behind a veil of extreme secrecy, Silicon Valley hype, and ‘I Want To Believe’. Babylon is working... Continue Reading